Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide plus furosemide for acute heart failure with volume overload under SGLT2 inhibitor therapy
jRCTs031230483Recruiting
- Sponsor
- Clinical Research Initiation-Fund (of Chiba University Hospital)
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of acetazolamide in Acute Heart Failure (AHF) (2 arms), sponsored by Clinical Research Initiation-Fund (of Chiba University Hospital). Primary endpoint: Cumulative natriuresis for three days. Started Nov 2023; status: recruiting.
02
Drugs
acetazolamide
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on jRCTs031230483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230483.